enVVeno Medical Corporation
NVNO
$2.36
-$0.1192-4.81%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -6.23M | -5.64M | -4.96M | -4.99M | -5.65M |
| Total Depreciation and Amortization | 122.00K | 129.00K | 136.00K | 141.00K | 134.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.14M | 997.00K | 958.00K | 1.07M | 1.24M |
| Change in Net Operating Assets | -134.00K | 240.00K | -46.00K | 230.00K | -701.00K |
| Cash from Operations | -5.11M | -4.28M | -3.91M | -3.55M | -4.97M |
| Capital Expenditure | -4.00K | -9.00K | -14.00K | -10.00K | -4.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -11.05M | 6.23M | 3.99M | 2.21M | -22.14M |
| Cash from Investing | -11.06M | 6.22M | 3.97M | 2.20M | -22.14M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 13.59M | 0.00 | 46.00K | 25.79M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 13.59M | 0.00 | 46.00K | 25.79M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.16M | 15.54M | 66.00K | -1.31M | -1.33M |
